The End of Medicine as We Know It

Understanding a person's genetic makeup is becoming easier every day... [Shield] AN OXFORD CLUB PUBLICATION [Wealthy Retirement]( [View in browser]( SPONSORED [AI Trading Tool 20 Years in the Making... Now Revealed LIVE!]( [Profit Summit - August 2]( Discover how one secret technology would have found same-day potential gains as high as 513%... 1,085%... even 1,367%... Be among the first to see this amazing breakthrough in action... and even see live trade setups. [We're LIVE Wednesday, August 2, at 2 p.m. ET - Click Here to Sign Up FREE]( Editor's Note: In today's column, we're sharing an article by The Oxford Club's Senior Markets Expert Matt Benjamin from the July issue of The Oxford Communiqué. In it, he explores what he believes will be the future of medicine in the U.S. We think you'll enjoy it. If you're interested in taking the guesswork out of your investments, check out Chief Investment Strategist Alexander Green's "[Single-Stock Retirement Play]( He believes [this stock]( has the makings of a "[Perfect Stock]( and could be the cornerstone of your retirement. [Find all of the imperative details here!]( - Rachel Gearhart, Associate Publisher [MARKET TRENDS]( [The End of One-Size-Fits-All Medicine]( [Matt Benjamin, Senior Markets Expert, The Oxford Club]( [Matt Benjamin]( Let's face it: Modern medicine relies on a considerable amount of educated guesswork. I'm not criticizing healthcare professionals, medical researchers, or the makers of drugs and medical devices. They do admirable - and often heroic - work. Advances in medicine have been reducing the death rate from cancer by several percentage points a year for decades. Deaths from cardiovascular disease have declined dramatically over the past century. And infectious diseases killed 19% fewer Americans in 2014 than they did in 1980. Treatments for a wide variety of diseases and ailments continue to improve dramatically and rapidly. Oxford Club Chief Investment Strategist Alexander Green likes to point out that Moderna (Nasdaq: MRNA) and Pfizer (NYSE: PFE) had COVID-19 vaccines ready for clinical trials within a couple of months of the pandemic reaching the U.S. The fastest vaccine development prior to this, for mumps in 1967, took four years. But we're all familiar with the experience of going to the doctor or the hospital and being told that a treatment that works for most people will probably work for us. And the process of determining the effectiveness of a treatment or drug for an individual often involves trial and error. That's because there is significant genetic diversity both across and within population groups. Our genetic differences impact our vulnerability to various diseases and affect how well we respond to specific treatments. We've long known that certain populations are more susceptible to particular diseases. For example, sickle cell anemia disproportionately affects people of African descent, and Tay-Sachs disease disproportionately affects people of Ashkenazi Jewish descent. But genetic differences between one population group and the next are modest. The vast majority of human genetic diversity is at the individual level, not between ethnic, geographical and racial groups. And that's been a major obstacle for modern medicine. SPONSORED [Self-Made Multimillionaire Reveals the Top Secret of the Ultra-Rich]( [Mega Yacht]( For the first time ever, multimillionaire investor Karim Rahemtulla is exposing [the most guarded secret of the ultra-rich](. He's revealing how America's top 0.1% collect huge, passive income... day after day after day. It's how Warren Buffett made TENS OF BILLIONS for his Berkshire Hathaway fund. Best of all... you don't have to be rich to benefit from this method too! [DISCOVER THE JUICY DETAILS OF THIS #1 SECRET]( Because of your individual genetic code, you might be at greater risk for certain diseases. And each of us can respond to a plethora of drugs and treatments in different ways. Indeed, small variations in your genetic code mean that you might not react well to a generally effective treatment or drug, or that you might experience greater side effects. Of course, this knowledge is not new. Doctors have always known that some individuals would not respond well to certain cures; they just couldn't determine who those individuals would be. Thus the guesswork that is often involved in medicine. Today, however, there is something they can do about it: It's called personalized, or precision, medicine. An Individual Approach Essentially, this emerging field of medicine is about determining important genetic traits in an individual in order to tailor a treatment regime to that person. "If doctors know your genes, they can predict drug response and incorporate this information into the medical decisions they make," said Dr. Rochelle Long, a pharmacogenomics expert at the National Institutes of Health. And understanding a person's genetic makeup is becoming easier every day due to various technologies that can handle the enormous amounts of data involved... [Reveal Genetic Advancements]( [Investment U Conference 2024 at the Ojai Valley Inn & Spa in Ojai, California. Don't miss out!]( RECOMMENDED LINKS ["My First Impression Was 'You've GOT to Be KIDDING Me!'" - Bill O'Reilly]( ["007" of Investing Reveals Top $1.1B+ Dealmaking Secrets. Click Here for No-Holds-Barred Presentation.]( MORE FROM WEALTHY RETIREMENT [Image of building your retirement]( [How to Build the Retirement of Your Dreams]( [Image of an energy sector concept]( [50 Ways to Invest in the Energy Sector]( [Image of hands of artificial intelligence robot and human touching]( [The No. 1 AI Stock to Avoid Right Now]( [Image of the AGNC stock logo]( [AGNC Stock: Can This Company Finally Sustain Its Double-Digit Yield?]( [Facebook]( [Facebook]( [Twitter]( [Twitter]( [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AUnderstanding a person%27s genetic makeup is becoming easier every day...%0D%0A%0D [Email Share](mailto:?subject=A%20great%20piece%20from%20Wealthy%20Retirement...&body=From%20Wealthy%20Retirement:%0D%0A%0D%0AUnderstanding a person%27s genetic makeup is becoming easier every day...%0D%0A%0D [Push Alert]( [Push Alert]( SPONSORED [Yours Free! Top FIVE Dividend Stocks Right Now]( Marc Lichtenfeld - income expert and author of Get Rich with Dividends - is giving away his Ultimate Dividend Package... completely free of charge! You'll discover... - An "A"-rated, ultra-safe dividend stock with a huge 8% yield - Three of Marc's favorite "Extreme Dividend" stocks, which could supercharge your income - And finally, Marc's No. 1 dividend stock for a LIFETIME of income. [Click here to get the names and ticker symbols now](... before the download link expires. **NO CREDIT CARD REQUIRED!** [The Oxford Club]( You are receiving this email because you subscribed to Wealthy Retirement. Wealthy Retirement is published by The Oxford Club. Questions? Check out our [FAQs](. Trying to reach us? [Contact us here.]( Please do not reply to this email as it goes to an unmonitored inbox. [Privacy Policy]( | [Whitelist Wealthy Retirement]( | [Unsubscribe]( © 2023 The Oxford Club, LLC All Rights Reserved The Oxford Club | [105 West Monument Street](#) | [Baltimore, MD 21201](#) North America: [877.808.9795](#) | International: [+1.443.353.4621](#) [Oxfordclub.com]( Nothing published by The Oxford Club should be considered personalized investment advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed personalized investment advice. We allow the editors of our publications to recommend securities that they own themselves. However, our policy prohibits editors from exiting a personal trade while the recommendation to subscribers is open. In no circumstance may an editor sell a security before subscribers have a fair opportunity to exit. The length of time an editor must wait after subscribers have been advised to exit a play depends on the type of publication. All other employees and agents must wait 24 hours after publication before trading on a recommendation. Any investments recommended by The Oxford Club should be made only after consulting with your investment advisor and only after reviewing the prospectus or financial statements of the company. Protected by copyright laws of the United States and international treaties. The information found on this website may only be used pursuant to the membership or subscription agreement and any reproduction, copying or redistribution (electronic or otherwise, including on the world wide web), in whole or in part, is strictly prohibited without the express written permission of The Oxford Club, LLC, 105 West Monument Street, Baltimore, MD 21201.